Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-12

Clinical Trial Update: Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions? [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating whether adding bevacizumab during glaucoma surgery improves the success of needle bleb revisions. Results were posted after completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)

Snippet

Sponsor: Wills Eye | Conditions: Glaucoma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-03-12